Glox Therapeutics appoints new Chair and new scientific advisory board member
The expanded team will support growth and development, and the commercialization of precision antibiotics to help overcome antimicrobial resistance
The expanded team will support growth and development, and the commercialization of precision antibiotics to help overcome antimicrobial resistance
Showcased at SLAS2025, Labtools.AI share the worlds first IBFC to generate cellular protein expression
Explore guidelines and recommendations for the design and generation of DNA constructs to generate a recombinant protein with the Cytiva Protein Select resin
BioPORTER protein delivery reagent from AMSBIO is proven to efficiently transport functionally active proteins directly into living cells eliminating the traditional DNA transfection, transcription, and protein translation process.
Dr. Ana de Oliveira from the Spatial Biology Core at UVA discusses the potential of the field to supercharge research across sectors
Dr. Priya Chockalingam discusses the complexities of cell and gene therapies and how single-cell multimodal analysis can efficiently characterize gene-edited products
In the fast-paced world of science, knowledge drives progress, and The Bio-Rad Academy leads the charge
Discover the latest technology to supercharge your gene therapy vector analysis workflow
A survey exploring the science behind cell and gene therapies highlights the tech at the heart of this breakthrough area
Explore the importance of this powerhouse protease across diverse research and product development applications and discover a standout proteinase K offering
New mRNA-based therapies and vaccines could be developed more quickly and cheaply thanks to new manufacturing technologies developed at the University of Sheffield
Global Head of Medical Affairs at Agilent Technologies offers insights into the technologies driving the field of precision oncology
Explore how the latest advancements and recent regulatory approvals are making truly personalized medicine a reality
As we celebrate the first regulatory approval of a gene-editing based therapeutic, Casgevy™, for the treatment of sickle cell disease and transfusion-dependent β-thalassemia, we consider the gene-editing challenges that must be overcome before CRISPR gene-editing technology becomes a common treatment modality
New study findings from the University of Manchester are important for the development of new wound therapies
Discover the impact of mass photometry in AAV process development in this exclusive interview with a viral vector expert
Experts share insights on protein complexity — offering tools and breakthrough discoveries that empower researchers to overcome obstacles in academia and industry
Watch this on-demand webinar to learn about monoclonal antibody-based human immune modulation in enhancing therapeutic outcomes
Discover how Sengenics’ protein microarray technology improves the reproducibility, specificity and biological relevance of proteomic assays
Talk to focus on the spinout journey from drug repurposing to clinical trials for diagnosing and treating Alzheimer’s disease
A comprehensive and interactive digital guide to advanced flow cytometry with assays, applications, and other resources
Explore the latest developments in cancer research with fellow scientists, manufacturers, and regulatory experts
This special feature highlights interviews and resources about the latest advances in cell and gene therapy and the technologies behind them
Designing and optimizing peptide sequences for targeted drug development using Flare
The launch of Do Bio celebrates the growth of the company's expertise in microfluidics and biology